 This is a non-randomized, open-label, single-dose study to compare the PK of 21-desacetyl-DFZ and, if data permits, deflazacort in 8 subjects with moderate hepatic impairment based on the Child Pugh classification, Grade B to that of 8 healthy matched control subjects age, body mass index BMI, and gender. 